Liver Institute at Methodist Dallas is a clinical research site located in Dallas, Texas, United States.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
Liver Institute at Methodist Dallas has participated in 8 clinical trials with 2 currently active.
Therapeutic areas: Hepatitis C, Chronic Hepatitis C, Primary Biliary Cirrhosis.
Sponsors: Vertex Pharmaceuticals Incorporated, Human Genome Sciences Inc., Gilead Sciences.
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Liver Institute at Methodist Dallas has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Liver Institute at Methodist Dallas has 8 clinical trials on record, with 2 currently active. Their work covers Hepatitis C, Chronic Hepatitis C, Primary Biliary Cirrhosis.
Yes — Liver Institute at Methodist Dallas holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.